Qube Research & Technologies (QRT)’s Angi Inc ANGI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-39,191
Closed -$604K 3531
2025
Q1
$604K Buy
+39,191
New +$668K ﹤0.01% 2477
2024
Q4
Sell
-2,677
Closed -$69.1K 3430
2024
Q3
$69.1K Sell
2,677
-9,577
-78% -$230K ﹤0.01% 2799
2024
Q2
$235K Sell
12,254
-1,635
-12% -$35.4K ﹤0.01% 2383
2024
Q1
$364K Buy
+13,889
New +$354K ﹤0.01% 2710
2023
Q4
Sell
-10,766
Closed -$213K 4317
2023
Q3
$213K Buy
10,766
+4,567
+74% +$131K ﹤0.01% 2377
2023
Q2
$205K Sell
6,199
-6,706
-52% -$188K ﹤0.01% 1770
2023
Q1
$293K Sell
12,905
-25,273
-66% -$647K ﹤0.01% 1771
2022
Q4
$897K Buy
38,178
+9,920
+35% +$222K ﹤0.01% 1266
2022
Q3
$834K Buy
28,258
+18,914
+202% +$833K 0.01% 1264
2022
Q2
$428K Buy
9,344
+3,276
+54% +$161K ﹤0.01% 1471
2022
Q1
$344K Buy
+6,068
New +$442K ﹤0.01% 1710
2020
Q4
Sell
-4,035
Closed -$448K 1783
2020
Q3
$448K Sell
4,035
-1,226
-23% -$169K 0.01% 1085
2020
Q2
$639K Buy
+5,261
New +$479K 0.01% 1018

Other funds holding ANGI

Qube Research & Technologies (QRT)'s ANGI Position: Q2 2025 in Review

Qube Research & Technologies (QRT) sold out of Angi Inc (ANGI) in Q2 2025, closing a stake of 39,191 shares — an estimated $604K sold.

Qube Research & Technologies (QRT) first reported a position in ANGI in Q2 2020 and held it in 13 quarters. The position peaked at $897K in Q4 2022. 258 funds tracked by Wall St. Rank hold ANGI as of Q2 2025.

  • Qube Research & Technologies (QRT) reported no remaining Angi Inc position as of Q2 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 39,191 Angi Inc shares in Q2 2025, an estimated $604K.
  • Qube Research & Technologies (QRT) first reported a position in Angi Inc in Q2 2020 and held it in 13 quarters.
  • Qube Research & Technologies (QRT)'s Angi Inc position peaked at $897K in Q4 2022.
  • 258 funds tracked by Wall St. Rank held Angi Inc as of Q2 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2025, filed 14 Aug 2025.